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A b s t r a c t
We have reported a bacterial infection in a dog with progressive dysplasia of the hips. Orthopedic surgery was performed. Seven weeks 
prior to the surgery, the patient was bitten by another dog. The postimplantation wound exuded for four days after the surgery. Microbiological 
analysis performed by standard identification techniques showed the presence of Staphylococcus intermedins, but an additional molecular 
analysis indicated S. pseudintermedius. This was followed by an evaluation of antibiotic susceptibility of the strain which showed cefoxitin, 
ciprofloxacin, clindamycin, trimethoprim/sulfamethoxazole, doksycycline, erythromycin, and gentamicin resistance. Minimal inhibitory 
concentration (MIC) values for selected antibiotics were reported. Resistance for cefoxitin indicates that methicillin resistant S. pseudintermedius 
(MRSP) strains were present in individual macroorgamsms, but they can expand and persist the colonization of other hosts.
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Description of the case. The host of the bacterial 
infection was a seven year old, non-castrated, 
Bergamasco Sheepdog weighing 40 kg before sur­
gery. For the past 4—5 years the dog displayed limp­
ing in the pelvic limb. Clinical examination of the dog 
revealed considerable crepitation. The dog had diffi­
culty standing up after prolonged rest and displayed 
increasing aversion to movement. Diagnostic radio­
graphy showed progressive dysplasia of the right hip 
and dysplasia of the left hip with degenerative changes. 
The patient was sent to an orthopedic surgeon who 
recommended prosthetic joint replacement surgery. 
Each implant procedure involved the removal of the 
damaged joint and an artificial prosthesis replace­
ment. Moreover, the owner of the dog reported that 
the dog had been bitten by a large five year old mixed- 
breed dog. After the bite the wound was cleaned and 
disinfected with the use of antiseptic substances, and 
also prophylactically ceftriaxon with metronidazole 
were applied. The incident occurred seven weeks 
prior to the surgery in the region of the right trochanster 
major femoral bone (distal to the area of the surgery). 
Four days after the implantation surgery, the wound
began to exude. At the beginning the volume of the 
discharge was about 5-8 ml a day, later it increased to 
about 30 ml. The dog had a fever and was apathetic, 
sore and did not eat. The wound healed up after a one- 
month treatment with linezolid. Three months after 
the surgery the prosthesis was removed. During the 
healing process three samples for microbiological 
analysis were taken. The first sample was taken from 
the seeping wound one week after the surgery. The 
second sample originated from the marrow cavity of 
the femoral bone during the removal of the prosthe­
sis. The third sample was taken from the skin around 
the scar after the healing process.
Microbiological diagnostics. Identification. Each 
sample was cultured in a blood agar medium (TSA+5% 
of sheep blood), in a selective medium for staphylo­
cocci (SAID, BioMerieux), and in a medium for rods 
(CPS, BioMerieux). The obtained cultures observed 
by microscopic testing demonstrated the presence of 
staphylococci which were then further analyzed by 
a free coagulase tube test and by an identification sys­
tem for staphylococci ID32 STAPH (BioMerieux). The 
bacteria were identified as S. intermedius. However,
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from our experience, the ID32 STAPH identification 
system may give ambiguous results for isolates of ani­
mal origin. Moreover the test does not include a re­
cently described coagulase-positive species -  S. pseu- 
dintermedius (Devriese et al., 2005). Therefore final 
identification of the isolates was performed using 
molecular analysis (Bannoehr et al., 2009; Black et al., 
2009). Among methods, including PCR-RFLP of 
glyceraldehyde-3 -phosphate dehydrogenase-encoding 
gene, sequencing of internal fragments of the 16S rRNA 
and rpoB genes, used for S. pseudintermedius identifi­
cation only the last is discriminatory (Wladyka et al., 
2008). For partial sequence analysis of the rpoB gene, 
PCR was performed according to the protocol descri­
bed by Drancourt and Raoult (Drancourt and Raoult, 
2002). The obtained fragment was sequenced with the 
primers used for the amplification. All three isolates 
had an identical sequence of the rpoB gene. Compari­
son of the sequence with the corresponding ones of 
S. pseudintermedius strains deposited in the EMBL 
database revealed either their full identity or one nucle­
otide difference between the strains, whereas homo­
logy with S. intermedius was only 95%. Therefore the 
isolates were finally identified as S. pseudintermedius. 
The sequence for the partial rpoB gene was deposited in 
the EMBL database under accession number FN556020.
Antimicrobial susceptibility testing. Evaluation 
of antibiotic susceptibility of the isolates was per­
formed by a disc-diffusion test, and an E-test (AB 
BIODISK) according to the guidelines set by the 
National Committee for Clinical Laboratory Standards 
(NCCLS), (Faires et al., 2009; Sasaki et al., 2007). The 
disc diffusion method with cefoxitin was used to ana­
lyze the methicillin resistance (Swenson et al., 2005). 
Additionally two discs, with erythromycin and clinda­
mycin, were used to examine resistance to macrolides, 
linkosamids, and streptogramins B. The methicillin re­
sistant S. pseudintermedius also showed resistance for 
macrolides, lincosamids and streptogramins B, impli­
cating the constitutive mechanism (MLSB constitutive). 
This was found in each of the taken samples. The 
results of antimicrobial testing are presented in Table I. 
The MIC values achieved from the E-tests performed 
for selected antibiotics are reported too.
The presence of a chromosomal cassette SCCmec 
type III encoding antibiotic multiresistance was con­
firmed using MULTIPLEX PCR analysis, which is 
a useful tool used for the identification of structural 
types and variants of the mec gene in staphylococci. 
Additionally, the isolates analyzed were compared to 
the standard strains (Oliveira and deLancastre, 2002).
Comments and conclusions. Accurate identifica­
tion of bacteria from the genus Staphylococcus isolated 
from animals or men is important from a laboratory 
diagnostics point of view, as well as in clinical prac­
tice. Some staphylococcal species are reported more
Table I
Antibiotic susceptibility o f the Staphylococcus 
pseudintermedius strain
Antibiotic




Cefoxitin 6 - resistant
Chloramphenicol 18 2.0 mg/1 sensitive
Ciprofloxacin 6 - resistant




Doksycycline 6 - resistant
Erythromycin* 6 - resistant
Fusidic acid 26 - sensitive
Gentamicin 6 - resistant
Linezolid 23 0.5 mg/1 sensitive
Mupirocin 30 - sensitive
Rifampicin 21 0.002 mg/1 sensitive
Teicoplanin** - 0.5 mg/1 sensitive
Vancomycin** - 1.5 mg/1 sensitive
* The result for erythromycin susceptibility is also representative for 
roxithromycin, clarithromycin, azithromycin, and dirithromycin.
** The diameter of the inhibition zone was not tested by the disc diffu­
sion method.
frequently than others in samples from infections, and 
exhibit an increasing level of antibiotic resistance. 
Many staphylococcal species belong to the normal 
biocenosis, however under favorable conditions the 
bacteria may cause serious infections. In the case 
described above we performed molecular analysis 
followed after the identification based on the biochemi­
cal characteristic of the pathogen isolated from the 
infection after the implantation of the prosthesis. The 
presence of S. intermedius, an opportunistic species 
participating in normal physiological biocenosis of 
healthy dogs was reported in routine diagnostic pro­
cedures (Hauschild and Wójcik, 2007). However the 
surgical intervention was the additional factor which 
favored bacteria to increase infection. Unfortunately, it 
is unknown if the strain was present in the skin before 
the bite or if it was introduced by the dog aggressor?
The samples for bacteriological examination were 
taken three times during the therapy process. From 
the first sample a rich culture of S. intermedius was 
achieved despite prior application of the antibiotic 
(ceftriaxon and metronidazole) to the patient. Based 
on the above observation, and on the antibiogram, 
linezolid was administrated to the dog (7.5 mg per 1 
kg of the body weight). Then from the second and the 
third samples only single Staphylococcus intermedius 
colonies were grown. All the isolates exhibited the 
same antibiotic resistance pattern.
Examinations of the S. intermedius group (SIG) 
show new challenges in diagnostics therefore the
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selection of techniques and tests for phenotypic and 
genetic analysis are in trial phases, so any informa­
tion on their properties is very valuable (Kizerwetter- 
Świda et al., 2009). Phenotypic typing methods used 
in standard diagnostic tests were not effective to dis­
criminate S. pseudintermedius from S. intermedius. 
Therefore, analysis of the partial rpoB gene sequence 
of the isolates was performed. The results showed that 
the isolates examined were identical and were classi­
fied as S. pseudintermedius. According to recent 
guidelines, strains isolated from dogs that are identi­
fied by standard biochemical tests as S. intermedius 
should be reported as S. pseudintermedius, and gen­
erally there is a need to elaborate the regulation sys­
tem when classifying the SIG group (Devriese et al., 
2009; Ruscher et al., 2009).
Due to surgery and adequate chemotherapy based 
on the antibiogram, the therapeutic process was con­
cluded successfully. The antibiogram indicated effec­
tive antibacterial medicines. Surprisingly, the exam­
ined isolate showed multi drug resistance, particularly 
for P-lactams, including methicillin, allowing classifi­
cation of the strain as a methicillin resistant S. pseu­
dintermedius (MRSP).
Temporary colonization of man by animal strains, 
the horizontal transfer of genes, and the antibiotic re­
sistance, including methicillin-resistance among animal 
isolates cause an alarming phenomenon which could 
result in dangerous clinical consequences in the future 
(Black et al., 2009; Weese and Van Duikeren, 2009).
In conclusion, we described the isolation of a me­
thicillin resistant S. pseudintermedius (MRSP) which 
was the etiological factor of a wound infection in the 
dog which was surgically operated because of dege­
nerative changes, but prior to the operation was bitten 
by another dog. This confirms the dangerous dissemi­
nation of drug resistance in staphylococci strains of 
animal origin. Phenomena of temporary colonization 
and carriage of such strains by dog owners, together 
with reports on S. pseudintermedius infections among 
humans (VanHoovels et al., 2006), led us to conclude 
that novel strains carrying antibiotic resistant genes 
will soon be reported. Thus, the establishment of 
new procedures and diagnostic schemes for both 
veterinary and human microbiology are an emerging 
challenge.
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